CEO: Wendel Barr.

Revenue: $42.1 million in 2010; $41.3 million in 2009.

No. of local employees: 220.

Investors: Gryphon Investors, San Francisco.

Headquarters: Carlsbad.

Year founded: 1995.

Company description: A full-service contract research organization serving biotechnology, medical device and pharmaceutical companies. Clinical trial expertise is focused on therapies related to oncology, the central nervous system, cardiovascular disease and ophthalmology.

Key factors for success: Synteract emphasizes customer service, with a 90 percent rate of repeat business.

Carlsbad-based Synteract Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129